Marjorie Sidhoum
Director de Operaciones en Domain Therapeutics SA .
Perfil
Marjorie Sidhoum is the founder of Almetis Cs SAS.
She is currently working as the Director of Business Operations at Domain Therapeutics SA and as a Director at Find Therapeutics.
Dr. Sidhoum obtained a doctorate degree from the University of Strasbourg.
Cargos activos de Marjorie Sidhoum
Empresas | Cargo | Inicio |
---|---|---|
Domain Therapeutics SA
Domain Therapeutics SA BiotechnologyHealth Technology Domain Therapeutics SA discovers and develops drug candidates targeting G-protein coupled receptors (GPCR) in all major therapeutic fields. The firm?s products include technologies, such as DTect-All and BioSens-All. Its services encompass allosteric modulators identification, biased ligands selection, orphan and historically intractable GPCRs address and high throughput screening campaign. The company was founded by Maurice Isra?l, Pierre Potier, Bernard Jacques Alex Gilly, Yves Dunant and Pascal Neuville in 2008 and is headquartered in Illkirch-Graffenstaden, France. | Director de Operaciones | - |
Find Therapeutics
Find Therapeutics BiotechnologyHealth Technology Find Therapeutics develops therapeutics for inflammatory and fibrotic disease. The company is headquartered in Saint-Laurent, Canada. | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Marjorie Sidhoum.
Empresas | Cargo | Fin |
---|---|---|
Almetis Cs SAS | Fundador | - |
Formación de Marjorie Sidhoum.
University of Strasbourg | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 3 |
---|---|
Domain Therapeutics SA
Domain Therapeutics SA BiotechnologyHealth Technology Domain Therapeutics SA discovers and develops drug candidates targeting G-protein coupled receptors (GPCR) in all major therapeutic fields. The firm?s products include technologies, such as DTect-All and BioSens-All. Its services encompass allosteric modulators identification, biased ligands selection, orphan and historically intractable GPCRs address and high throughput screening campaign. The company was founded by Maurice Isra?l, Pierre Potier, Bernard Jacques Alex Gilly, Yves Dunant and Pascal Neuville in 2008 and is headquartered in Illkirch-Graffenstaden, France. | Health Technology |
Almetis Cs SAS | |
Find Therapeutics
Find Therapeutics BiotechnologyHealth Technology Find Therapeutics develops therapeutics for inflammatory and fibrotic disease. The company is headquartered in Saint-Laurent, Canada. | Health Technology |
- Bolsa de valores
- Insiders
- Marjorie Sidhoum